ArticleFrontiers in immunology2025
A prediction model based on machine learning: prognosis of HBV-induced HCC male patients with smoking and drinking habits after local ablation treatment.
Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Article
- Prognostic nomogram for recurrence free survival in elderly patients with HBV related hepatocellular carcinoma and diabetes from a multicenter study.Discover oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Liver cancer, particularly hepatocellular carcinoma (HCC), is a major health concern globally and in China, possibly shows recurrence after ablation treatment in high-risk patients. This study investigates the prognosis of early-stage male HCC patients with chronic hepatitis virus B (HBV) infection who also have long-term smoking and drinking habits, following local ablation treatment. Methods: Data from 257 patients treated at Capital Medical University, Beijing Youan Hospital from 2014 to 2022 were retrospectively analyzed. We first screened the variables by Lasso regression and random survival forest (RSF), followed by multivariate Cox regression analysis. Based on the screened variables after these steps, we performed and validated a nomogram to predict the survival status of these patients. Results: Our results indicated that monocytes and globulin are risk factors while pre-albumin (PALB) is protective after selected by Lasso, RSF and multivariate Cox regression, providing a robust tool for predicting overall survival and guiding treatment for high-risk HCC patients. With promising discrimination, accuracy and clinical applicability, our model was translated into a nomogram for practical use. Conclusion: Our prognostic model effectively identifies key risk factors such as monocytes, globulin and PALB, providing accurate predictions for HBV-induced male patients with smoking and drinking habits.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.